FIELD: medicine.
SUBSTANCE: invention relates to the field of medicine, oncology and can be used for radionuclide diagnosis of lung cancer. The method reduces number of complications associated with radiation exposure on the body. Radiopharmaceutical 199Tl is administered intravenously and the scintigraphy examination of early and delayed phase is implemented after intravenous administration of radiopharmaceutical with visual control of loci of radiopharmaceutical superfixation. At that 199Tl is administered in a dose of 270 Mbc, and the studies are conducted in the mode of single-photon computed tomography.
EFFECT: method of radionuclide diagnosis of lung cancer is proposed.
1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR EVALUATING BRAIN PERFUSION | 1995 |
|
RU2116800C1 |
METHOD OF DIAGNOSING TUMOUR PROCESS DISSEMINATION IN PATIENTS WITH NON-SMALL-CELL LUNG CARCINOMA | 2011 |
|
RU2454931C1 |
METHOD OF RADIONUCLIDAL DIAGNOSTICS OF LARYNGEAL AND PHARYNGOPHARYNGEAL CANCER | 2017 |
|
RU2679298C1 |
METHOD OF RADIONUCLIDAL DIAGNOSTICS OF BREAST CANCER | 2017 |
|
RU2682880C1 |
METHOD FOR RADIONUCLIDE DIAGNOSTICS OF LUNG CANCER | 2020 |
|
RU2751103C1 |
METHOD FOR RADIONUCLIDE DIAGNOSING OPERABLE BREAST CANCER WITH OVEREXPRESSION OF HER2/NEU | 2019 |
|
RU2702294C1 |
METHOD OF RADIONUCLIDE BREAST CANCER DIAGNOSTICS | 2007 |
|
RU2371202C2 |
METHOD FOR RADIONUCLIDE DIAGNOSTICS OF MALIGNANT LYMPHOMAS | 2018 |
|
RU2706602C1 |
METHOD FOR RADIONUCLIDE DIAGNOSING OF CEREBRAL TUMORS | 2017 |
|
RU2692451C2 |
METHOD OF DIFFERENTIAL DIAGNOSIS OF NONSPECIFIC INFLAMMATORY AND MALIGNANT TUMOUR PROCESSES OF MUSCULOSCELETAL SYSTEM | 2007 |
|
RU2323685C1 |
Authors
Dates
2010-08-27—Published
2008-09-01—Filed